文献速递角膜与眼表疾病

加速角膜交联:疗效、进展风险及影响结局的特征——大型单中心前瞻性研究

Accelerated Corneal Cross-Linking: Efficacy, Risk of Progression, and Characteristics Affecting Outcomes. A Large, Single-Center Prospective Study.
PubMed 文献 · Am J Ophthalmol · 2020-01-13

该前瞻性单中心观察性队列研究纳入612眼(391例)进展性圆锥角膜、透明边缘性角膜变性及LASIK术后角膜扩张患眼,评估加速角膜交联(9 mW/cm² 10分钟)疗效。术后1年平均最大角膜曲率(Kmax)无显著变化,但基线Kmax>58D及14-18岁亚组Kmax进展比例更高。术前最佳 spectacle 矫正视力、Kmax、屈光、角膜柱镜、彗差、中央角膜厚度及视觉功能为结局的显著预测因素(P<.001);术前 apical scarring 与 haze 加重、散光增加、中央角膜变薄相关,但对内皮有保护作用。

要点

  • 加速CXL术后1年平均Kmax稳定,但基线Kmax>58D及14-18岁患者进展风险更高,需密切监测。
  • 术前BSCVA、Kmax、屈光、角膜柱镜、彗差、CCT及视觉功能是结局的显著预测因素(P<.001)。
  • 术前apical scarring与haze加重、散光增加、中央角膜变薄相关,但对内皮有保护作用。

核心结论

  • 加速CXL术后1年平均Kmax稳定。
  • 年轻患者及术前Kmax较高者需密切监测进展。
  • 术前BSCVA、地形图、屈光、CCT及apical scarring是结局的显著预测因素。

研究设计与样本

  • 前瞻性单中心观察性队列研究。
  • 纳入612眼(391例),包括进展性圆锥角膜589眼、透明边缘性角膜变性11眼、LASIK术后角膜扩张12眼。
  • 评估术前及术后12个月的BSCVA、地形图、屈光、内皮细胞密度、角膜厚度、haze、眼压及视觉功能。
  • 采用多变量线性回归模型分析种族、年龄、性别、术前apical scarring及环境过敏对结局的影响。

主要发现

  • 术后1年平均Kmax无显著变化(n=569)。
  • 基线Kmax>58D亚组(n=191)及14-18岁亚组(n=53)Kmax进展比例更高。
  • 术前BSCVA、Kmax、屈光、角膜柱镜、彗差、中央角膜厚度及视觉功能为结局的显著预测因素(P<.001)。
  • 术前apical scarring导致haze加重(P=.0001)、散光增加(P=.002)、中央角膜变薄(P=.002),但对内皮有保护作用(P=.008)。
  • 种族、年龄及性别影响部分结局。

关键数值与推荐

  • 加速CXL方案:9 mW/cm²照射10分钟。
  • 术后1年平均Kmax无显著变化(n=569)。
  • 基线Kmax>58D(n=191)及14-18岁(n=53)亚组Kmax进展比例更高。
  • 术前BSCVA、Kmax、屈光、角膜柱镜、彗差、中央角膜厚度及视觉功能预测结局(P<.001)。
  • 术前apical scarring与haze加重(P=.0001)、散光增加(P=.002)、中央角膜变薄(P=.002)相关,对内皮有保护作用(P=.008)。

临床怎么用

  • 对年轻及术前Kmax较高的患者,加速CXL术后应密切监测Kmax进展。
  • 术前应评估BSCVA、地形图、屈光、CCT及apical scarring以预测加速CXL结局。

局限性

  • 单中心观察性研究,随访仅12个月。
  • 部分亚组样本量较小(如14-18岁组n=53)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We examined the efficacy and preoperative characteristics that affect outcomes of accelerated (9 mW/cm2 for 10 minutes) corneal cross-linking (CXL). DESIGN: Prospective single-center observational cohort study. METHODS: We enrolled 612 eyes of 391 subjects with progressive keratoconus (n = 589), pellucid marginal degeneration (n = 11), and laser in situ keratomileusis-induced ectasia (n = 12). We evaluated best spectacle-corrected visual acuity (BSCVA), topography, refraction, endothelial cell density, corneal thickness, haze, intraocular pressure, and visual function before and 12 months after the CXL procedure. We tabulated the proportion of those with progression of maximum keratometry (Kmax). We included participant's race, age, sex, and the presence of preoperative apical scarring and environmental allergies in a multivariable linear regression model to determine the effect of these characteristics on outcomes. RESULTS: At 1 year there was no significant change in mean Kmax (n = 569). Progression of Kmax was higher in subgroups with a baseline Kmax >58 diopters (n = 191) and those 14-18 years of age (n = 53). Preoperative BSCVA, Kmax, refraction, corneal cylinder, coma, central corneal thickness, and vision function were statistically and clinically significant predictors of outcomes (P < .001). Preoperative apical scarring led to worsening haze (P = .0001), more astigmatism (P = .002), more central corneal thinning (P = .002), and was protective to the endothelium (P = .008). Race, age, and sex affected some outcomes. CONCLUSION: Mean Kmax was stable at 1 year after accelerated CXL. Younger patients and those with a higher preoperative Kmax need to be monitored closely for progression. Preoperative BSCVA, topography, refraction, CCT, and apical scarring were significant predictors of outcomes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Hatch W, El-Defrawy S, Ong Tone S, et al. Accelerated Corneal Cross-Linking: Efficacy, Risk of Progression, and Characteristics Affecting Outcomes. A Large, Single-Center Prospective Study. Am J Ophthalmol. 2020. PMID: 31945333. doi:10.1016/j.ajo.2020.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。